Kolexia
Passeron Thierry Dermatologie
Passeron Thierry
Dermatologie
Hôpital De l'Archet
Nice, France
511 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Vitiligo Mélanome Tumeurs cutanées Psoriasis Mélanose Hyperpigmentation Maladies de la peau Pelade Hidrosadénite

Collaborateurs

Voir plus
Lacour Jean Philippe
Lacour Jean Philippe
Hôpital De l'Archet, Nice, France
Montaudie Henri
Montaudie Henri
Hôpital De l'Archet, Nice, France
Bahadoran Philippe
Bahadoran Philippe
Hôpital De l'Archet, Nice, France
Leccia Nathalie
Leccia Nathalie
Hôpital Pasteur, Nice, France

Industries

Voir plus
Novartis
64 collaboration(s)
Dernière en 2023
Janssen
61 collaboration(s)
Dernière en 2023
Lilly
53 collaboration(s)
Dernière en 2023
Abbvie
51 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation
Essai Clinique (CHU Nice)   15 mars 2024
Vitiligo BL: Translational Assessment of Vitiligo According to Body Locations Translational Study
Essai Clinique (CHU Nice)   15 mars 2024
MFC: Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients as Compared to Controls
Essai Clinique (CHU Nice)   15 mars 2024
A Bayesian network meta-analysis of 14 molecules inhibiting UV daylight-induced pigmentation.
Journal of the European Academy of Dermatology and Venereology : JEADV   03 mars 2024
BRAVE-AA-PEDS: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Essai Clinique (Lilly)   28 février 2024
Study of Daxdilimab (HZN-7734) in Patients With Moderate-to-Severe Primary Discoid Lupus Erythematosus: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Investigate the Efficacy and Safety of Daxdilimab Subcutaneous Injection in Reducing Disease Activity in Adult Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus
Essai Clinique (Horizon Therapeutics Ireland DAC)   12 février 2024
Clinical Images: A Strange Reaction After a Hyaluronic Acid Injection.
Arthritis & rheumatology (Hoboken, N.J.)   05 février 2024
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials.
The British journal of dermatology   16 janvier 2024
VITANI: Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo: a Randomized Double Blind Prospective, Non Comparative Proof of Concept Phase II Study
Essai Clinique (AstraZeneca)   18 décembre 2023
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
JAMA dermatology   06 décembre 2023